Advertisement

A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T cell function and therapy of murine leukemia

Shannon K. Oda, Andrew W. Daman, Nicolas M. Garcia, Felecia Wagener, Thomas M. Schmitt, Xiaoxia Tan, Aude G. Chapuis and Philip D. Greenberg

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted April 3, 2017
  • Accepted October 12, 2017
  • Published online October 17, 2017.


Contributors 
  • Shannon K. Oda, 1 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Andrew W. Daman, 1 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Nicolas M. Garcia, 1 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Felecia Wagener, 1 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Thomas M. Schmitt, 1 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Xiaoxia Tan, 2 Department of Immunology, University of Washington, Seattle, WA, United States
  • Aude G. Chapuis, 1 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Philip D. Greenberg, 1 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output